Skip to main content
Microbix Biosystems Inc. logo

Microbix Biosystems Inc. — Investor Relations & Filings

Ticker · MBX ISIN · CA59501P1045 TSX Manufacturing
Open in API
Filings indexed 214 across all filing types
Latest filing 2026-04-20 Regulatory Filings
Country CA Canada
Listing TSX MBX

About Microbix Biosystems Inc.

https://microbix.com/

Microbix Biosystems Inc. develops and commercializes proprietary biological and technological solutions for human health, specializing in infectious disease diagnostics. The company is a commercial-scale producer of infectious disease antigens, which are utilized as key ingredients in manufacturing diagnostic tests and for vaccine research and development. Microbix also provides a comprehensive portfolio of external quality control materials (EQC), marketed as Quality Assessment Products (QAPs™). These whole-workflow, multi-analyte controls, available in liquid and swab formulations for IVD and Research Use Only (RUO) applications, support clinical laboratory proficiency testing and assay development across various infectious disease panels, including respiratory, STI, HPV, and gastrointestinal pathogens. The company is ISO 9001 and 13485 accredited, serving the global diagnostics industry.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing the release of podcast episodes featuring discussions with industry experts. It contains no financial statements, no regulatory filings, no voting results, no management changes, no earnings data, and no detailed financial or operational reports. It is primarily a corporate communication about a media initiative (podcast) and includes forward-looking statements. The document length is 6898 characters, which is relatively short and does not contain any financial report or regulatory filing content. Therefore, it does not fit into categories like Annual Report, Interim Report, Earnings Release, or Regulatory Filings. It is best classified as a general Regulatory Filing (RNS) as a miscellaneous announcement that does not fit other categories.
2026-04-20 English
News release - English.pdf
Regulatory Filings Classification · 60% confidence The document is a corporate news release announcing that Microbix will be presenting at an upcoming investor conference. It does not contain financial results (so not ER), actual investor slide content (so not IP), nor any other specific regulatory filings like board changes, dividends, or share transactions. It is an announcement of a planned presentation/event and therefore does not fit any of the more specific categories. As such, it defaults into the general regulatory/announcement fallback category: RNS.
2026-04-16 English
News release - English.pdf
Regulatory Filings Classification · 80% confidence The document is a corporate news release announcing Microbix’s exhibition and presentation at the ESCMID Global 2026 conference, describing product showcases and forward-looking statements. It does not contain financial results (so it’s not an earnings release), nor is it a full or interim report, investor presentation, dividend notice, or other specific regulatory filing category. It is effectively a general corporate announcement, so it falls under the fallback category of Regulatory Filings (RNS).
2026-04-15 English
Notice of the meeting and record date (amended) - English.pdf
AGM Information Classification · 98% confidence The document is a formal notice from TSX Trust Company to exchanges and commissions regarding the upcoming Annual Meeting of Security Holders for Microbix Biosystems Inc. It specifies the record dates, meeting date, and proxy-related delivery instructions. This type of document is a standard regulatory notification regarding the logistics of an upcoming shareholder meeting, which falls under the category of Regulatory Filings (RNS) as it does not contain the actual proxy materials (PSI) or the meeting presentation (AGM-R) itself.
2026-02-05 English
News release - English.pdf
Report Publication Announcement Classification · 100% confidence The document is a press release from Microbix Biosystems Inc. announcing the upcoming release of their Q1 2026 financial results and a scheduled webinar. It does not contain the actual financial results, but rather informs the public of the timing and logistics for the future release. Following the 'Menu vs Meal' rule, this is classified as a Report Publication Announcement (RPA).
2026-02-05 English
Notice of the meeting and record date - English.pdf
AGM Information Classification · 98% confidence The document is a formal notice from TSX Trust Company to exchanges and commissions regarding the upcoming Annual and Special Meeting of Microbix Biosystems Inc. It specifies record dates, meeting dates, and proxy-related logistics. This type of document is a standard regulatory notification regarding meeting logistics and proxy-related procedures, which falls under the category of Regulatory Filings (RNS) as it does not constitute the proxy statement itself (PSI) or the meeting presentation (AGM-R).
2026-01-12 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.